GPX3 and ovarian clear cell adenocarcinoma: While the mechanism behind overexpression of GPx3 in patients with clear cell ovarian adenocarcinoma is unclear, GPx3 was shown to contribute to platinum and taxane-based chemoresistance [118,130].